Q3 2024 · 13F-HR
RA CAPITAL MANAGEMENT, L.P.holdings as filed
Filed 2024-11-14 · accession 0001104659-24-119034
$8.67B
Reported value
81
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S - ADR | $1.45B | 16.7% | 9,710,428 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $992.9M | 11.4% | 8,689,190 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $416.4M | 4.80% | 9,165,652 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP-ADR | $365.8M | 4.22% | 7,506,934 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $318.8M | 3.68% | 6,084,412 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $289.4M | 3.34% | 6,300,408 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $244.9M | 2.82% | 10,416,609 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC - A | $240.8M | 2.78% | 8,514,862 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $237.8M | 2.74% | 8,909,091 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $229.6M | 2.65% | 1,184,456 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $229.2M | 2.64% | 6,381,144 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT INC | $193.6M | 2.23% | 3,916,825 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $177.2M | 2.04% | 6,955,993 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $159.9M | 1.84% | 31,419,267 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $157.5M | 1.82% | 10,860,977 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $154.6M | 1.78% | 1,851,479 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $152.2M | 1.76% | 9,853,302 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $149.3M | 1.72% | 18,202,009 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $146.6M | 1.69% | 32,285,755 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC - ADR | $144.1M | 1.66% | 5,009,653 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA CO NV | $133.9M | 1.54% | 8,064,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $115.2M | 1.33% | 1,961,863 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $109.7M | 1.26% | 7,871,721 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $104.9M | 1.21% | 14,175,398 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS-A | $101.4M | 1.17% | 15,384,615 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $99.2M | 1.14% | 4,178,823 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $91.4M | 1.05% | 10,689,545 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $89.9M | 1.04% | 1,000,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $83.2M | 0.96% | 1,896,772 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $65.3M | 0.75% | 2,538,925 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $63.9M | 0.74% | 2,333,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $58.7M | 0.68% | 4,850,984 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $58.4M | 0.67% | 8,340,508 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $56.2M | 0.65% | 5,105,213 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $55.1M | 0.64% | 5,098,211 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $52.7M | 0.61% | 1,397,433 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC-ADR | $51.0M | 0.59% | 2,253,000 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $48.8M | 0.56% | 10,805,129 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $46.0M | 0.53% | 2,210,589 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $44.7M | 0.52% | 6,686,689 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $43.8M | 0.51% | 761,955 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $42.7M | 0.49% | 1,347,252 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $39.6M | 0.46% | 6,045,351 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $39.3M | 0.45% | 1,511,334 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $37.0M | 0.43% | 14,932,063 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $36.5M | 0.42% | 10,229,099 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $32.5M | 0.37% | 3,184,711 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $30.2M | 0.35% | 4,330,446 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $27.8M | 0.32% | 4,878,000 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $27.1M | 0.31% | 1,061,233 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $23.7M | 0.27% | 2,075,154 | Common | SOLE |
| 81749D107 | SERA | SERA PROGNOSTICS INC-A | $23.7M | 0.27% | 3,032,808 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $21.9M | 0.25% | 10,872,503 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $20.0M | 0.23% | 1,750,000 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $19.2M | 0.22% | 9,192,092 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC-A | $18.0M | 0.21% | 176,281 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $17.4M | 0.20% | 1,280,826 | Common | SOLE |
| 929033108 | — | VOR BIOPHARMA INC | $15.9M | 0.18% | 22,748,880 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $14.6M | 0.17% | 200,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $14.4M | 0.17% | 1,281,000 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $13.5M | 0.16% | 6,982,587 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $13.1M | 0.15% | 3,217,503 | Common | SOLE |
| 95075A107 | HOWL | WEREWOLF THERAPEUTICS INC | $13.0M | 0.15% | 6,144,881 | Common | SOLE |
| 15713L109 | CRVO | CERVOMED INC | $11.9M | 0.14% | 817,120 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $11.6M | 0.13% | 575,000 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $10.9M | 0.13% | 7,541,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $10.4M | 0.12% | 421,348 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $9.2M | 0.11% | 967,000 | Common | SOLE |
| 16934W106 | CMRXEUR | CHIMERIX INC | $8.2M | 0.09% | 8,800,000 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $7.6M | 0.09% | 2,180,631 | Common | SOLE |
| 171757206 | CDTX | CIDARA THEREAPEUTICS INC | $7.6M | 0.09% | 703,080 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAPITAL SOLUTIONS | $7.5M | 0.09% | 750,000 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $4.9M | 0.06% | 546,554 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTIC INC | $3.5M | 0.04% | 1,900,000 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MEDICAL HOLDINGS INC | $3.4M | 0.04% | 1,333,926 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $3.4M | 0.04% | 282,580 | Common | SOLE |
| 59102M104 | MGX | METAGENOMI INC | $2.8M | 0.03% | 1,305,239 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA CO NV-27 | $2.3M | 0.03% | 333,333 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $2.1M | 0.02% | 1,999,997 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $1.2M | 0.01% | 766,834 | Common | SOLE |
| 80880W106 | SCLXUSD | SCILEX HOLDING CO | $241,486 | 0.00% | 261,179 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.